← back to search

Wei Zhao

Xinjiang Medical University · CN
Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research interests include RNA modifications and cancer, Lymphoma Diagnosis and Treatment, Genomics and Phylogenetic Studies, and Microbial Natural Products and Biosynthesis.
h-index
36
citations
5,533
works
275
NIH funding
primary concept
email

Recent publications

Closed-loop enhancement of plant photosynthesis via biomass-derived carbon dots in biohybrids
Communications Materials 2025cited by 29position: middledoi
Identification of Rhododendron mariae extraction as a new attachment inhibitor against dengue virus by targeting the envelope protein domain III
Frontiers in Immunology 2025cited by 0position: middledoi
RT-RPA-Cas12a-based assay facilitates the discrimination of SARS-CoV-2 variants of concern
Sensors and Actuators B Chemical 2023cited by 21position: lastdoi
Engineering conjugative CRISPR-Cas9 systems for the targeted control of enteric pathogens and antibiotic resistance
PLoS ONE 2023cited by 17position: middledoi
Phase separation modulates the assembly and dynamics of a polarity-related scaffold-signaling hub
Nature Communications 2022cited by 44position: lastdoi
Universally Stable and Precise CRISPR-LAMP Detection Platform for Precise Multiple Respiratory Tract Virus Diagnosis Including Mutant SARS-CoV-2 Spike N501Y
Analytical Chemistry 2021cited by 88position: middledoi
Schistosoma japonicum SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE)
Frontiers in Immunology 2020cited by 16position: middledoi
Red-Emissive Carbon Dots for Fingerprints Detection by Spray Method: Coffee Ring Effect and Unquenched Fluorescence in Drying Process
ACS Applied Materials & Interfaces 2017cited by 337position: middledoi
Self-Assembled ZnO Nanoparticle Capsules for Carrying and Delivering Isotretinoin to Cancer Cells
ACS Applied Materials & Interfaces 2017cited by 48position: firstdoi
ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects
ACS Nano 2016cited by 117position: middledoi
Drug Discovery via Human-Derived Stem Cell Organoids
Frontiers in Pharmacology 2016cited by 66position: lastdoi
Complete genome sequence and comparative genomic analyses of the vancomycin-producing Amycolatopsis orientalis
BMC Genomics 2014cited by 77position: lastdoi
Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
PLoS ONE 2012cited by 147position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guoping Zhao · ZheJiang Academy of Agricultural Sciences3 papers (2014–2023)Huan‐Ming Xiong · Fudan University3 papers (2016–2017)Jingxian Sun · Harbin Medical University2 papers (2022–2023)Guiyue Tang · Shanghai University2 papers (2022–2023)Peng Zhang · Fudan University2 papers (2017–2017)Yingying Li · Guangzhou University of Chinese Medicine2 papers (2022–2023)Helmuth Möhwald · Max Planck Institute of Colloids and Interfaces2 papers (2016–2017)Jilie Kong · Fudan University2 papers (2016–2017)Wei Tan · Jilin University2 papers (2022–2023)Kezhu Cai · Southern University of Science and Technology2 papers (2022–2023)Jishi Wei · National University of Singapore2 papers (2017–2017)Jie Chen · Ministry of Education of the People's Republic of China2 papers (2017–2017)Zhixiong Liu · Central South University1 papers (2016–2016)Ning Lü · Shandong University1 papers (2022–2022)Wenbo Cheng · Guizhou University1 papers (2025–2025)Huihui Cao · Guangzhou University of Chinese Medicine1 papers (2025–2025)Sarah Wu · University of Colorado Boulder1 papers (2023–2023)Weihong Jiang · Case Western Reserve University1 papers (2014–2014)Xuemei He · Xiamen University1 papers (2025–2025)Jiakun Liu · Harbin Institute of Technology1 papers (2023–2023)